Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Ann Oncol
; 29(5): 1235-1248, 2018 05 01.
Article
in En
| MEDLINE
| ID: mdl-29529169
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Abiraterone Acetate
/
Docetaxel
/
Androgen Antagonists
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2018
Type:
Article